Medipal Secures KRW 5 Billion in Series A

by Kay Aloha Villamor in November 6th, 2023

Medipal, a South Korea-based aftercare SaaS solution company, has secured KRW 5 billion in Series A funding, bringing its total funding to KRW 7 billion.

SaaS Investors

Bass Investment and Insight Equity Partners, existing investors, participated in this round, with KT Investment joining as a new investor.

Medipal Use of Funds

With this investment, The company will help first and second-tier clinics become central players in local healthcare and further enhance the continuity of patient care.

About Medipal

Medipal is a digital health startup that operates the patient re-visit management solution AfterDoc for clinics and medical practices. Medipal's AfterDoc platform, launched in 2021, helps medical clinics with post-appointment tasks, patient health monitoring, daily health consulting, and appointment management. 

Funding Details

Company: Medipal, Inc. 

Raised: KRW 5 Billion

Round: Series A

Funding Month: November 2023

Lead Investors: 

Additional Investors: Bass Investment, Insight Equity Partners, KT Investment 

Company Website: 

Software Category: Aftercare SaaS Solution


Your cart